National

Covid-19: The daily dose (June 18, 2021)

| Updated on June 18, 2021

We curate for you all the Covid-19-related developments and stories of the day worth reading

# Russia’s sovereign wealth fund RDIF has offered a Sputnik V booster shot against the Delta variant, the worrying cause behind the surge in coronavirus cases in India, and in other parts of the world.

https://www.thehindubusinessline.com/companies/rdif-to-offer-booster-shot-to-other-vaccine-makers/article34843012.ece

# At a time when vaccine exports from India have been paused, here’s why Dr Arora believes there would be enough to share by next year.

https://www.thehindubusinessline.com/news/national/india-will-have-enough-vaccines-by-march-to-share-with-the-world/article34842917.ece

# Australia joins the list of countries restricting the AstraZeneca-Oxford Uuniversity vaccine, in this case, among those below 60 years. India, though, has maintained it has not found any reason to bring in such age restrictions.

https://www.thehindubusinessline.com/companies/australia-restricts-use-of-az-oxford-vaccine-to-those-over-60/article34842903.ece

# Serum is hopeful of starting trials of the Novavax Covid-19 vaccine in adolescents.

https://www.thehindubusinessline.com/news/national/serum-institute-to-start-novavax-trials-in-adolescents-next-month/article34842946.ece

# The Centre is stepping on the gas, when it comes to medicines to treat black fungus.

https://www.thehindubusinessline.com/news/national/govt-identifies-new-sources-to-procure-black-fungus-drugs/article34841732.ece

# And finally, while researchers and investigators look in bat-caves and leaky labs for the origins of SARS-CoV-2, a key message on zoonotic viruses is written large on the wall. And it has to do with our agri-farming practices and trade in wild animals.

https://www.thehindubusinessline.com/opinion/clean-up-the-stables/article34842368.ece?homepage=true

Published on June 18, 2021

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor